Good morning! 

Hope all is well and here is my little reminder! We got a really good offer for you if you want to attend WONDERLAND, the first psychedelic conference in IRL in a year, hosted by https://microdose.buzz/. The line-up? Well, everyone will be there, and me too. 

And here is your special The New Health Club offer! The code “TNHC” will give you $500 off the business tickets.

But, wait there is more.

The New Health Club and Field Trip Health /Netherlands will cooperate starting mid-November. You will be the first one to know about our magic truffle venture! 

But now over to my incredible podcast guest! 

My guests today are Daniel Goldberg and Tim Schlidt, founders of the Palo Santo fund. The two of them and their really impressive team got a big plan for the coming years: investing across the new psychedelic ecosystem and funding a new paradigm in well-being.

Palo Santo’s diversified investment fund is helping to increase the supply of clinically effective and accessible mental health and addiction treatment solutions needed in today’s world.

Daniel Goldberg began seeing mental health as part of a spectrum and not something that needs to be so pathologized. As a founder of Palo Santo and Bridge Investments, Daniel has been actively investing with and supporting inspired entrepreneurs for 20 years. Years ago he saw the transformational potential of psychedelic medicines and has developed a deep network of relationships across the psychedelic research and business communities. His passion for the space is purpose‐driven and science-informed. He is thrilled to be a part of Palo Santo’s mission of supporting promising treatments while ensuring widespread access to safe, legal, and effective solutions.

Tim Schlidt brings extensive knowledge investing across life sciences and healthcare services and has held a lifelong passion for understanding and improving treatments for CNS disorders. He believes psychedelics are poised to shift the paradigm in mental health treatment and his primary mission in co-founding Palo Santo is to invest in companies and solutions that allow for broad access to those most in need of mental health care. Prior to co-founding Palo Santo, Tim covered the life sciences and health care services sectors as a private equity investor at Madison Dearborn Partners and an investment banker at J.P. Morgan and Greenhill.

We talk about Daniel’s and Tim’s personal psychedelic experience they had BEFORE the founding of Palo Santo, the shift and the incredible change they saw coming, when a new generation of scientists engaged in psychedelics, about the psychedelic pharma model and what compound is Daniel’s and Tim’s favorite and we chat about what will possibly be happening and what I will see, if I would dare to take 5 MEO DMT: but that will happen on the next episode.

Aaaad don't forget, this episode with Palo Santo is sponsored by “Plant Medicine Law Group” the American boutique law firm serving the psychedelic and cannabis space. 

PMLG was founded by three women in November 2020. Their mission is to expand equitable and legal access to plant medicine and help companies in the psychedelic and cannabis industries succeed in a complex, emerging market. PMLG provides clients with strategic expertise to successfully launch, fund, and grow their businesses.

I got to know Adriana Kertzer, one of PMLG's founding partners, during a digital conference. She then invited me to join the interfaith working group Faith + Psychedelics. Plant Medicine Law Group's goal is to help entrepreneurs in the psychedelic and cannabis industries succeed in complex and emerging industries. 

They’re committed to humanizing the legal process and empowering you with the information and guidance you need to build the next generation of successful businesses. The PMLG team embraces complexity, encourages innovation, and aligns themselves directly with your vision.

Talk to you soon,

Anne

Get full access to The New Health Club, by Anne Philippi at thenewhealthclub.substack.com/subscribe